Tech Company Financing Transactions

Citryll Funding Round

Citryll secured a $89 million Series B funding round on 12/9/2024. Backers included Forbion Capital Partners, Johnson & Johnson Development Corporation and Novartis Venture Fund.

Transaction Overview

Company Name
Citryll
Announced On
12/9/2024
Transaction Type
Venture Equity
Amount
$89,000,000
Round
Series B
Investors

Forbion Capital Partners (Lead Investor)

Johnson & Johnson Development Corporation (Lead Investor)

Novartis Venture Fund (Lead Investor)

BioGeneration Ventures

BOM

Curie Capital

Pureos Bioventures

Seventure Partners

Proceeds Purpose
The company intends to use the funds to enable next steps for the clinical development of CIT-013, a monoclonal antibody which targets Neutrophil Extracellular Traps (NETs), a fundamental component of the inflammatory process that has yet to be addressed therapeutically.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Building RK Kloosterstraat 9
Oss, 5349 AB
The Netherlands
Phone
Undisclosed
Website
www.citryll.com
Email Address
Not Recorded
Overview
Citryll is pioneering an innovative approach to immune mediated inflammatory diseases. Targeting NETs as a fundamental but previously unaddressed component of inflammation, Citryll is going beyond individual pathway management and symptom treatment to reduce inflammatory drive at the source.
Profile
Citryll LinkedIn Company Profile
Social Media
Citryll Company Twitter Account
Company News
Citryll News
Facebook
Citryll on Facebook
YouTube
Citryll on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Eduardo Bravo
  Eduardo Bravo LinkedIn Profile  Eduardo Bravo Twitter Account  Eduardo Bravo News  Eduardo Bravo on Facebook
Chief Marketing Officer
Maarten Kraan
  Maarten Kraan LinkedIn Profile  Maarten Kraan Twitter Account  Maarten Kraan News  Maarten Kraan on Facebook
Chief Operating Officer
Leonie Middelink
  Leonie Middelink LinkedIn Profile  Leonie Middelink Twitter Account  Leonie Middelink News  Leonie Middelink on Facebook
Chief Operating Officer
Sjoerd van Gorp
  Sjoerd van Gorp LinkedIn Profile  Sjoerd van Gorp Twitter Account  Sjoerd van Gorp News  Sjoerd van Gorp on Facebook
Chief Scientific Officer
Eric Meldrum
  Eric Meldrum LinkedIn Profile  Eric Meldrum Twitter Account  Eric Meldrum News  Eric Meldrum on Facebook
Chief Technical Officer
Renato Chirivi
  Renato Chirivi LinkedIn Profile  Renato Chirivi Twitter Account  Renato Chirivi News  Renato Chirivi on Facebook
VP - Bus. Development
Tim Schenk
  Tim Schenk LinkedIn Profile  Tim Schenk Twitter Account  Tim Schenk News  Tim Schenk on Facebook

 

 

Browse more venture capital transactions:

Prev: 12/9/2024: Element451 venture capital transaction
Next: 12/9/2024: Truss venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.